Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #128091 on Biotech Values
genisi
10/25/11 10:46 AM
#129328 RE: DewDiligence #128091
Given the uncertainties associated with academic and government research funding and the global economic environment, the company is implementing a restructuring to better align the company’s organization and cost structure. As a result, the company expects to record a restructuring charge of approximately $15-17 million, the majority of which will be recorded during the fourth quarter of 2011
11/30/11 5:56 PM
#132122 RE: DewDiligence #128091